Considering Toxicities and Side Effects of JAK Inhibitors in Patients with MF
Dr Jamile Shammo discusses how to approach sequencing therapies in patients with myelofibrosis and Dr Raajit Rampal explains the potential of the JAK inhibitor momelotinib in the treatment of myelofibrosis.
Raajit Rampal Jamile Shammo Expert Insights Into Side Effects Myeloproliferative Neoplasms Management Of Mpns
Source: onclive.com